Try our beta test site
2550 studies found for:    "Schizophrenia and Disorders with Psychotic Features"
Show Display Options
Rank Status Study
1 Completed The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
Condition: Schizophrenia and Disorders With Psychotic Features
Interventions: Drug: Minocycline;   Drug: Placebo
2 Not yet recruiting Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
Condition: Schizophrenia and Disorders With Psychotic Features
Interventions: Dietary Supplement: Jobelyn;   Drug: Haloperidol
3 Unknown  Social Skills Training in Refractory Schizophrenia
Condition: Schizophrenia and Disorders With Psychotic Features
Intervention: Behavioral: Social Skills Training
4 Recruiting PACT for Individuals With Serious Mental Illness
Condition: Schizophrenia and Disorders With Psychotic Feature
Intervention: Other: Patient Aligned Care Team (PACT)
5 Completed
Has Results
Specialized Treatment Early in Psychosis (STEP)
Condition: Schizophrenia and Disorders With Psychotic Features
Interventions: Behavioral: Cognitive Behavioral Group Therapy;   Behavioral: Cognitive remediation;   Drug: Medications;   Behavioral: MFG;   Behavioral: Assertive case management;   Other: Treatment as Usual in the community
6 Terminated
Has Results
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Condition: Schizophrenia and Disorders With Psychotic Features
Intervention: Drug: Ziprasidone HCL (oral)
7 Unknown  Investigator Initiated Study - Asenapine Early Psychosis
Conditions: Schizophrenia and Disorders With Psychotic Features;   Disorders
Intervention: Drug: Asenapine
8 Completed
Has Results
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Conditions: Schizophrenia and Disorders With Psychotic Features;   Tobacco Use Disorder
Interventions: Drug: Bupropion;   Drug: Contingent reinforcement plus placebo;   Drug: non-contingent reinforcement plus bupropion;   Drug: Non-contingent reinforcement plus placebo
9 Completed Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
Conditions: Schizophrenia and Disorders With Psychotic Features;   Tobacco Use Disorder
Intervention:
10 Not yet recruiting Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians
Condition: Schizophrenia Spectrum and Other Psychotic Disorders
Intervention: Behavioral: Social Skills Coach
11 Completed Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
Conditions: Schizophrenia and Disorders With Psychotic Features;   Tobacco Use Disorder;   Schizophrenia
Interventions: Drug: Transdermal Nicotine Patch;   Drug: 21 mg transdermal nicotine;   Drug: placebo patch
12 Active, not recruiting Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Conditions: Schizophrenia;   Schizophrenia and Disorders With Psychotic Features;   Schizoaffective Disorders
Interventions: Drug: Olanzapine;   Drug: Amisulpride;   Drug: Risperidone;   Drug: Haloperidol;   Drug: Quetiapine;   Drug: Perphenazine;   Drug: Sulpiride;   Drug: bromperidol;   Drug: Zuclopenthixol;   Drug: Thioridazine;   Drug: Paliperidone;   Drug: Ziprasidone;   Drug: Benperidol;   Drug: Fluspirilene;   Drug: Pimozide;   Drug: Perazine;   Drug: Fluphenazine;   Drug: Flupentixole;   Drug: Sertindole
13 Completed Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
Conditions: Schizophrenia and Disorders With Psychotic Features;   Affective Psychosis, Bipolar;   Psychoses
Intervention:
14 Enrolling by invitation Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
Conditions: Schizophrenia and Disorders With Psychotic Features;   Affective Disorders, Psychotic;   Self Concept
Intervention:
15 Completed Low Pulse Amplitude Seizure Therapy (LAP-ST Study)
Conditions: Mood Disorders;   Schizophrenia Spectrum and Other Psychotic Disorders
Intervention: Device: Mecta spectrum 5000Q device
16 Enrolling by invitation 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Conditions: Schizophrenia;   Schizophrenia Relapse;   Schizophrenia Spectrum and Other Psychotic Disorders
Interventions: Other: Antipsychotic treatment discontinuation;   Other: Maintenance treatment discontinuation
17 Completed 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Conditions: Schizophrenia;   Schizophrenia Relapse;   Schizophrenia Spectrum and Other Psychotic Disorders
Interventions: Other: Antipsychotic treatment discontinuation;   Other: Maintenance antipsychotic treatment
18 Completed A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Placebo/Cannabidiol;   Drug: Cannabidiol/Placebo
19 Not yet recruiting Berberine as Adjuvant Treatment for Schizophrenia Patients
Conditions: Schizophrenia;   Schizophrenia Spectrum and Other Psychotic Disorders;   Metabolic Syndrome x
Interventions: Drug: Berberine;   Drug: Placebos;   Drug: Antipsychotic Agents
20 Completed Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
Conditions: Mental Disorders;   Mood Disorders;   Personality Disorders;   Schizophrenia and Disorders With Psychotic Features
Interventions: Procedure: Resource-oriented music therapy;   Procedure: Standard care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.